Detalhe da pesquisa
1.
Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.
J Immunol
; 211(2): 219-228, 2023 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37204246
2.
Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.
Lancet Oncol
; 24(4): e161-e171, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36990614
3.
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 24(2): 162-174, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36623515
4.
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.
Lancet Oncol
; 24(8): e344-e354, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37541280
5.
Brain metastasis as the first and only metastatic relapse site portends worse survival in patients with advanced HER2 + breast cancer.
Breast Cancer Res Treat
; 197(2): 425-434, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36403183
6.
Available Systemic Treatments and Emerging Therapies for Breast Cancer Brain Metastases.
Curr Treat Options Oncol
; 24(6): 611-627, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37071254
7.
Systemic Therapy Approaches for Breast Cancer Brain and Leptomeningeal Metastases.
Curr Treat Options Oncol
; 23(10): 1457-1476, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36136177
8.
Systemic management of brain metastases in HER2+ breast cancer in 2022.
Clin Adv Hematol Oncol
; 20(5): 325-336, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35579591
9.
Current multidisciplinary management of brain metastases.
Cancer
; 126(7): 1390-1406, 2020 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31971613
10.
Clinicopathologic features of breast cancer reclassified as HER2-amplified by fluorescence in situ hybridization with alternative chromosome 17 probes.
Ann Diagn Pathol
; 48: 151576, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32805517
11.
Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
Cancer
; 125(17): 2945-2954, 2019 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31090930
12.
Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
Oncologist
; 24(6): 762-771, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30552158
13.
ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases.
Future Oncol
; 15(19): 2211-2225, 2019 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-31074641
14.
Live birth outcomes after adolescent and young adult breast cancer.
Int J Cancer
; 142(10): 1994-2002, 2018 05 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29266267
15.
Erratum: Multidisciplinary Management of Breast Cancer During Pregnancy.
Oncologist
; 23(6): 746, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-31329729
16.
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Breast Cancer Res Treat
; 171(3): 637-648, 2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-29938395
17.
Discerning Clinical Responses in Breast Cancer Based On Molecular Signatures.
Am J Pathol
; 187(10): 2199-2207, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28822803
18.
Breast cancer in adolescents and young adults.
Pediatr Blood Cancer
; 65(12): e27397, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30156052
19.
Dual HER2-Targeting in the Adjuvant Setting: Where We Have Been and Where We Are Going.
Oncology (Williston Park)
; 32(10): 483-7, 2018 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30334236
20.
Nivolumab plus ipilimumab in melanoma brain metastases - Authors' reply.
Lancet Oncol
; 23(2): e54, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35114123